New treatments for pulmonary fibrosis?

被引：11

作者：

Egan, JJ ^{[1
]}

机构：

[1] Wythenshawe Hosp, NW Lung Ctr, Manchester M23 9LT, Lancs, England

来源：

LANCET | 1999年 / 354卷 / 9193期

关键词：

D O I：

10.1016/S0140-6736(99)00347-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1839 / 1840

页数：2

共 15 条

[1] Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis [J].

Bjoraker, JA ;

Ryu, JH ;

Edwin, MK ;

Myers, JL ;

Tazelaar, HD ;

Schroeder, DR ;

Offord, KP .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) :199-203

[2] IMPROVEMENT IN PULMONARY-HYPERTENSION AND HYPOXEMIA DURING NITRIC-OXIDE INHALATION IN A PATIENT WITH END-STAGE PULMONARY FIBROSIS [J].

CHANNICK, RN ;

HOCH, RC ;

NEWHART, JW ;

JOHNSON, FW ;

SMITH, CM .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :811-814

[3] AN IMBALANCE BETWEEN THE EXCRETION OF THROMBOXANE AND PROSTACYCLIN METABOLITES IN PULMONARY-HYPERTENSION [J].

CHRISTMAN, BW ;

MCPHERSON, CD ;

NEWMAN, JH ;

KING, GA ;

BERNARD, GR ;

GROVES, BM ;

LOYD, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :70-75

[4] Pulmonary fibrosis: cytokines in the balance [J].

Coker, RK ;

Laurent, GJ .

EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (06) :1218-1221

[5] Survival in patients with cryptogenic fibrosing alveolitis - A population-based cohort study [J].

Hubbard, R ;

Johnston, I ;

Britton, J .

CHEST, 1998, 113 (02) :396-400

[6] RANDOMIZED CONTROLLED TRIAL COMPARING PREDNISOLONE ALONE WITH CYCLOPHOSPHAMIDE AND LOW-DOSE PREDNISOLONE IN COMBINATION IN CRYPTOGENIC FIBROSING ALVEOLITIS [J].

JOHNSON, MA ;

KWAN, S ;

SNELL, NJC ;

NUNN, AJ ;

DARBYSHIRE, JH ;

TURNERWARWICK, M .

THORAX, 1989, 44 (04) :280-288

[7] Idiopathic pulmonary fibrosis - Clinical relevance of pathologic classification [J].

Katzenstein, ALA ;

Myers, JL .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (04) :1301-1315

[8] Interstitial lung disease clinics for the management of idiopathic pulmonary fibrosis: A potential advantage to patients [J].

Lok, SS .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (09) :884-890

[9] Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis [J].

Olschewski, H ;

Ghofrani, HA ;

Walmrath, D ;

Schermuly, R ;

Temmesfeld-Wollbrück, B ;

Grimminger, F ;

Seeger, W .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) :600-607

[10] Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone - Results of a prospective, open-label phase II study [J].

Raghu, G ;

Johnson, WC ;

Lockhart, D ;

Mageto, Y .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (04) :1061-1069

← 1 2 →